MedTrace Logo

Neuroinflammation in Chronic Systemic Symptoms (CSS)

NCT04636723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-01-26

No results posted yet for this study

Summary

The purpose of the present research protocol is to investigate and identify translocator protein 18kDa, MRI DTI, and EEG/ERPs, markers of Chronic Systemic Symptoms (CSS).

Conditions

Sponsors & Collaborators

  • Vanderbilt-Ingram Cancer Center

    collaborator OTHER

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Poppy Schoenberg, PhD · Osher Center for Integrative Medicine, VANDERBILT UNIVERSITY MEDICAL CENTER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2021-12-07
Completion
2021-12-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04636723 on ClinicalTrials.gov